MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
Background/Aims: The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of triste...
Main Authors: | Xian-Jun Sun, Bing-Yan Liu, Shuo Yan, Ting-Hui Jiang, Hui-Qin Cheng, Hao-Sheng Jiang, Yan Cao, Ai-Wu Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-09-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/430389 |
Similar Items
-
The functional characterization of phosphorylation of tristetraprolin at C-terminal NOT1-binding domain
by: Hsin-Hui Hsieh, et al.
Published: (2021-06-01) -
The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond
by: Hung-Yu Lin, et al.
Published: (2020-04-01) -
miR-182-5p attenuates Schistosoma japonicum-induced hepatic fibrosis by targeting tristetraprolin
by: Zhao Xuejun, et al.
Published: (2022-09-01) -
Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin
by: Yong Wun Cho, et al.
Published: (2014-12-01) -
Tristetraprolin Gene Single-Nucleotide Polymorphisms and mRNA Level in Patients With Rheumatoid Arthritis
by: Xiaoke Yang, et al.
Published: (2021-09-01)